Emerald Plants Health Source (OCTQB:STNN) (“EPHS” or the “Company”) and Pure Global Cannabis Inc. (TSXV:PURE and OTC: PRCNF (“Pure”) are pleased to announce the companies have entered into a memorandum of understanding (“MOU”) through which the parties shall seek to enter into a wholesale supply agreement (“Supply Agreement”) whereby Pure will purchase 1,000 kg of dried flower from EPHS. The total quantity will be shipped periodically throughout a 12-month period commencing on or about July 2019, as product becomes available.
EPHS’s downtown Montreal facility prides itself on its capabilities to cultivate premium, craft grown cannabis at a market leading costs per gram. Lower cost of cultivation combined with ultra premium outputs places EPHS in an advantageous position within the cannabis landscape, for both the medical and adult-use markets. With over 350,000 square feet of cultivation canopy slated for their second site in Merritt, B.C, the smaller Montreal site will continue to be used as a craft growlab and a site to perfect automated environments for the larger Merritt play.
“We are thrilled to be supplying Pure with our signature ‘Craft Grown with Care’ cannabis, cultivated at our downtown Montreal facility. The firming of this relationship is a testament to our unique cultivation process, and the team behind it,” says Steven Perry, President of EPHS. “The team at Pure aligns with our mission and vision of providing both the medical and adult-use markets with the best possible quality of dried flower.”
This agreement follows EPHS achieving their cultivation license in late October 2018. EPHS has since been focused on acquiring unique genetics, enhancing their proprietary cultivation environment and the acquisition of land for the larger facility in Merritt, B.C.
“Pure Global is continuously looking for ways to get the highest quality products for distribution to our clinics, patients, and our online customers,” says Malay Panchal, President and CEO of Pure Global. “The production method and superior product from EPHS ensures that we can deliver on our corporate promise.”
ABOUT PURE GLOBAL CANNABIS
Pure Global Cannabis Inc. (TSX.V:PURE;OTC: PRCNF; FRA:1QS) is an innovation-based cannabis company led by experienced pharma, biotechnology, horticultural, and consumer packaged goods (CPG) experts. The Company’s wholly owned subsidiary, PureSinse Inc., is a licensed producer under the Cannabis Act. The Company’s Brampton campus houses facilities for vertically farmed cultivation, R&D, extraction, manufacturing, and distribution. Pure Global will produce branded and white-labeled cannabis products for the medical, pharmaceutical, wellness, health & beauty, natural health, food & beverage, and recreational legal markets with uniquely formulated and purified concentrates. The Company is using the Canadian market as a springboard to develop and manufacture GMP-compliant cannabis products for international sale and distribution with a goal to become one of the most trusted premium international cannabis brands.
EPHS Holdings Inc. (OCTQB: STNN) is a Montreal based wellness-focused company and licensed producer of connoisseur-quality craft grown cannabis, pursuant to the Cannabis Regulations under the Cannabis Act (Canada). With over 25 years of combined cannabis cultivation and power management experience, the team at EPHS will provide the Canadian and global cannabis markets with connoisseur-quality craft grown cannabis at the lowest possible cost. EPHS is committed to fostering B2B relationships along with purchasing, licensing, and/or developing authentic brands to support its craft quality cultivation outputs.
FORWARD LOOKING STATEMENTS
Certain statements contained in this news release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on expectations, estimations, and projections at the time the statements are made, and involve risks and uncertainties which could cause actual results or events to differ materially from those currently anticipated, including, but not limited to, delays, difficulties, changed strategies, or unanticipated factors or circumstances affecting EPHS Holdings Inc. and its business. Any forward-looking statement speaks only as of the date on which the statement is made, and, except as required by law, the Company does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for the Company to predict all such factors. When considering these forward-looking statements, one should be mindful of the risk factors and other cautionary statements found in the Company’s filings with the SEC, including, but not limited to, its Form 10, its subsequent Quarterly Reports on Form 10-Q, and its Current Reports on Form 8-K. The risk factors and other factors noted in the Company’s SEC filings could cause actual results to differ materially from those contained in any forward-looking statement.
About Emerald Plants Health Source
Both locations expand access to the state’s widest-ranging inventory of medical cannabis products for Central Florida patients
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two brand-new Central Florida dispensaries. The new Clearwater and Tampa locations mark the Company’s 81 st and 82 nd nationwide, respectively, widening patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”
HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005322/en/